# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Gainers
Gainers
Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics annou...
Gainers
U.S. stocks traded slightly higher toward the end of trading session on Wednesday following the announcement of interest rate d...
On Wednesday, 340 stocks hit new 52-week lows.
Gainers